Fig. 6From: The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritisLiraglutide ameliorates inflammation in the knee OA rat model. Representative Western blots and quantification data for TNF-α, IL-6 and IL-1β in the “OA”, “OA + saline” and “OA + liraglutide” groups (n = 5 per group). * indicates P < 0.05 compared with the “OA + saline” groupBack to article page